ArticleAnnals of African medicine2026
Antineutrophilic Cytoplasmic Antibodies Negative Vasculitic Neuropathy.
Article in Annals of African medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
abstractAntineutrophil cytoplasmic antibodies (ANCA) associated vasculitis (AAA) is a systemic disorder involving small vessels. Neuropathy may be associated with the involvement of other organs such as the kidneys, lungs, and heart. ANCA is detected in only 80%-90% of cases; hence, high degree of clinical suspicion is required. We report a case of 49-year-old male patient who had a known case of type-2 Diabetes mellitus and chronic kidney disease on regular peritoneal dialysis. He developed progressive tingling and burning paresthesia and weakness in all four limbs. Examination revealed quadriparesis, hypotonia, areflexia, and sensory loss in the glove and stocking pattern. The nerve conduction study was suggestive of severe generalized axonal sensorimotor neuropathy. He had rapidly progressive breathlessness. High-resolution computed tomography of the chest revealed bilateral ground-glass opacities with interstitial thickening suggestive of interstitial lung disease. He was treated with biweekly hemodialysis. He suffered a cardiac arrest due to an acute myocardial infarction and was successfully revived. Given multisystem involvement, the possibility of small vessel vasculitis was kept. Antinuclear antibodies and ANCA were negative. Sural nerve biopsy was reported as an inflammatory axonopathy, probably vasculitic. The patient was treated as a case of seronegative ANCA with six cycles of injection cyclophosphamide followed by immunosuppression with injection rituximab. He made a steady neurological recovery over 2 years with improved muscle power to grade 3 in both lower limbs and grade 4 in both upper limbs. ANCA may be negative in 10%-20% of cases. AAA should be strongly suspected in the presence of axonal neuropathy with evidence of multisystem involvement. A nerve biopsy can clinch the diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.